drugset / Trial / NCT01904110

To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women

NCT01904110

Phase 4 Completed 196 enrolled Hanlim Pharm. Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the Efficacy and the Safety of Monthly(RisenexM group) versus Weekly Oral risedronate(Risenexsplus group) in Korean postmenopausal osteoporotic women(Phase IV)

Timeline

Start
2012-12
Primary completion
2014-05-29
Completion
2016-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified Oral
Subject Risedronate Small molecule Oral

Indications